RM
Ramanuj Mukherjee
About Ramanuj Mukherjee
Data last updated:
Ramanuj Mukherjee has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Delbruk Lifescience Private Limited and Delbruk Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Delbruk Lifescience Private Limited at ₹9.41 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Apr 2020 | 2020 | ₹9.41 Cr (FY 2025) | Active | |
| Director | 20 Jan 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramanuj Mukherjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramanuj Mukherjee
Ramanuj Mukherjee has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Delbruk Lifescience Private Limited and Delbruk Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Delbruk Lifescience Private Limited at ₹9.41 Cr (FY 2025).
Ramanuj Mukherjee is associated with 2 companies as Director, including Delbruk Lifescience Private Limited (₹9.41 Cr), Delbruk Pharmaceuticals Private Limited.
Ramanuj Mukherjee has expertise in General Business.
Ramanuj Mukherjee has 6 years in corporate governance.
By reported revenue, the largest current company of Ramanuj Mukherjee is Delbruk Lifescience Private Limited, with revenue of ₹9.41 Cr (FY 2025).
Ramanuj Mukherjee currently holds positions at 2 companies: Delbruk Lifescience Private Limited (₹9.41 Cr), Delbruk Pharmaceuticals Private Limited.